BCRX
BioCryst Pharmaceuticals Inc.
Latest News for BCRX
In a report released today, Laura Chico from Wedbush maintained a Buy rating on BioCryst, with a price target of $21.00. Chico covers the Healthcar......
In a report released yesterday, Brian Abrahams from RBC Capital maintained a Buy rating on BioCryst, with a price target of $15.00. The company’s s......
In a report released today, Gena Wang from Barclays maintained a Hold rating on BioCryst, with a price target of $9.00. The company’s shares closed......
In a report released today, Serge Belanger from Needham maintained a Buy rating on BioCryst, with a price target of $18.00. The company’s shares cl......
In a report released today, Stacy Ku from TD Cowen maintained a Buy rating on BioCryst, with a price target of $30.00. The company’s shares opened ......
News data is sourced from MarketXLS API and updated regularly.
Showing 5 of 5 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCRX | $6.97 | -0.9% | 3.91M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioCryst Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW